title: Comparison between low frequency magnetic field stimulation and nerve growth factor treatment of cultured chromaffin cells, on neurite growth, noradrenaline release, excitable properties, and grafting in nigrostriatal lesioned rats.
abstract: Adrenal chromaffin cells in vitro respond to nerve growth factor (NGF) by expressing neuronal traits. Low frequency magnetic (LFM) field stimulation, while inducing a variety of effects on several cell types, has never been studies as to its effects on chromaffin cell cultures. The purpose of this study was to compare the effects of LFM field stimulation with that of NGF on the morphological phenotype, on noradrenaline (NA) release, and on membrane excitability of cultured chromaffin cells. We also tested the effects of grafting LFM and NGF-treated chromaffin cells into the caudate nucleus of rats with 6-hydroxydopamine lesions of the nigrostriatal pathway. The results of this study showed that LFM field stimulation produced neurite growth of cultured chromaffin cells in a manner similar to that of NGF exposure. The combination of the two procedures did not induce changes above those observed by NGF alone. Both NGF- and LFM-treated chromaffin cells released [3H]NA equally in response to a depolarizing concentration of KCl. On the other, Na+ current density of LFM field stimulation increased, but to a lesser extent than that seen in NGF-treated cells. In addition both types of cells when transplanted into nigrostriatal-lesioned animals induced a similar decrease in the motor asymmetries produced by the lesion. When NGF- or LFM-treated chromaffin cells where compared to untreated control cells, no significant differences were observed in [3H]NA release, on Na+ current densities, or on postgraft motor asymmetries. The results are discussed in terms of the fact that LFM-stimulated cells can be differentiated in a manner similar to NGF-treated cells, by acquiring sympathetic like traits which in turn can diminish motor asymmetries when grafted into nigrostriatal-lesioned rats.
authors.affiliation: Departamento de Fisiología, Facultad de Medicina, Univesidad Nacional Autónoma de México, México D.F.
authors.forename: R
authors.initials: R
authors.lastname: Drucker-Colín
authors.forename: L
authors.initials: L
authors.lastname: Verdugo-Díaz
authors.forename: M
authors.initials: M
authors.lastname: Méndez
authors.forename: J
authors.initials: J
authors.lastname: Carrillo-Ruiz
authors.forename: C
authors.initials: C
authors.lastname: Morgado-Valle
authors.forename: A
authors.initials: A
authors.lastname: Hernández-Cruz
authors.forename: G
authors.initials: G
authors.lastname: Corkidi
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D001921:Brain / Q000502:physiology*; D017690:Cell Transplantation; D002478:Cells, Cultured; D002838:Chromaffin System / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D003342:Corpus Striatum / Q000502:physiology; D004558:Electric Stimulation / Q000379:methods; D004594:Electrophysiology; D007150:Immunohistochemistry; D008280:Magnetics; D009414:Nerve Growth Factors / Q000494:pharmacology*; D016501:Neurites / Q000502:physiology*; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D012964:Sodium / Q000502:physiology; D013378:Substantia Nigra / Q000502:physiology
chemical_list: D009414:Nerve Growth Factors; D012964:Sodium; D009638:Norepinephrine